Procurement Summary
Country: USA
Summary: Noi Maldi Biotyper Sirius Ca System
Deadline: 27 May 2026
Posting Date: 18 Apr 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 139737199
Document Ref. No.: 26-004462
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Description:
This is a Notice of Intent, not a request for quotation (RFQ). A solicitation document will not be issued, and quotations will not be requested.
The National Institutes of Health (NIH), Clinical Center (CC), Office of Purchasing and Contracts (OPC), on behalf of the Department of Laboratory Medicine (DLM), intends to award a Firm-Fixed-Price (FFP) sole source purchase order to:
Bruker Scientific, LLC
40 Manning Road
Billerica, MA 01821
Requirement Description:
The Microbiology Service requires the MALDI Biotyper Sirius CA System to support the rapid and accurate identification of microorganisms, including bacteria, fungi, and mycobacteria, from clinical cultures.
Background:
The Department of Laboratory Medicine currently utilizes a Bruker MALDI Biotyper Smart System as its primary platform for microbial identification from clinical patient specimens. This system is essential for the identification of bacteria from clinical cultures and is also used for identification of fungi and mycobacteria.
The MALDI Biotyper Sirius CA System, manufactured exclusively by Bruker Scientific, LLC, is the direct successor to the currently deployed platform and is uniquely capable of meeting the Government-s requirements while maintaining continuity of operations. The system must be a direct successor to the existing platform to minimize validation requirements and avoid disruption to clinical laboratory operations.
The Sirius system is compatible with existing consumables, reagents, workflows, and validated methodologies currently in use within the Microbiology Service. Transitioning to a different manufacturer-s platform would require substantial validation and verification of clinical assays to meet regulatory and accreditation requirements, as well as retraining of personnel and modification of laboratory processes. This would result in significant duplication of effort, increased costs, and potential delays in diagnostic testing.br...
Notice ID: 26-004462
Department/Ind. Agency: health and human services, department of
Sub-tier: national institutes of health
Office: national institutes of health olao
Product Service Code: 6640 - laboratory equipment and supplies
NAICS Code: 334516 - Analytical Laboratory Instrument Manufacturing
Inactive Dates: jun 11, 2026
Inactive Policy: 15 days after response date
Documents
Tender Notice
Documents.zip